Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 3.26
STAA's Cash to Debt is ranked higher than
59% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. STAA: 3.26 )
Ranked among companies with meaningful Cash to Debt only.
STAA' s 10-Year Cash to Debt Range
Min: 0.08  Med: 1.72 Max: 9.66
Current: 3.26
0.08
9.66
Equity to Asset 0.66
STAA's Equity to Asset is ranked higher than
64% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. STAA: 0.66 )
Ranked among companies with meaningful Equity to Asset only.
STAA' s 10-Year Equity to Asset Range
Min: 0.29  Med: 0.66 Max: 0.81
Current: 0.66
0.29
0.81
F-Score: 3
Z-Score: 7.36
M-Score: -2.64
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -11.83
STAA's Operating margin (%) is ranked lower than
74% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. STAA: -11.83 )
Ranked among companies with meaningful Operating margin (%) only.
STAA' s 10-Year Operating margin (%) Range
Min: -37.38  Med: -10.13 Max: 23.93
Current: -11.83
-37.38
23.93
Net-margin (%) -12.71
STAA's Net-margin (%) is ranked lower than
72% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. STAA: -12.71 )
Ranked among companies with meaningful Net-margin (%) only.
STAA' s 10-Year Net-margin (%) Range
Min: -35.56  Med: -11.67 Max: 21.61
Current: -12.71
-35.56
21.61
ROE (%) -23.46
STAA's ROE (%) is ranked lower than
78% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. STAA: -23.46 )
Ranked among companies with meaningful ROE (%) only.
STAA' s 10-Year ROE (%) Range
Min: -88.78  Med: -25.41 Max: 21.13
Current: -23.46
-88.78
21.13
ROA (%) -15.14
STAA's ROA (%) is ranked lower than
76% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. STAA: -15.14 )
Ranked among companies with meaningful ROA (%) only.
STAA' s 10-Year ROA (%) Range
Min: -43.45  Med: -13.89 Max: 15.35
Current: -15.14
-43.45
15.35
ROC (Joel Greenblatt) (%) -32.56
STAA's ROC (Joel Greenblatt) (%) is ranked lower than
72% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. STAA: -32.56 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STAA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -131.74  Med: -28.88 Max: 83.59
Current: -32.56
-131.74
83.59
Revenue Growth (3Y)(%) 5.00
STAA's Revenue Growth (3Y)(%) is ranked higher than
50% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. STAA: 5.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STAA' s 10-Year Revenue Growth (3Y)(%) Range
Min: -12.5  Med: -6.70 Max: 14.8
Current: 5
-12.5
14.8
» STAA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

STAA Guru Trades in Q3 2014

Chuck Royce 233,276 sh (unchged)
Steven Cohen 31,500 sh (-71.23%)
» More
Q4 2014

STAA Guru Trades in Q4 2014

Steven Cohen Sold Out
Chuck Royce Sold Out
» More
Q1 2015

STAA Guru Trades in Q1 2015

Jim Simons 17,600 sh (New)
» More
Q2 2015

STAA Guru Trades in Q2 2015

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with STAA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 22.47
STAA's Forward P/E is ranked lower than
57% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.74 vs. STAA: 22.47 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 7.29
STAA's P/B is ranked lower than
86% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. STAA: 7.29 )
Ranked among companies with meaningful P/B only.
STAA' s 10-Year P/B Range
Min: 1.38  Med: 6.02 Max: 17.54
Current: 7.29
1.38
17.54
P/S 3.95
STAA's P/S is ranked lower than
63% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. STAA: 3.95 )
Ranked among companies with meaningful P/S only.
STAA' s 10-Year P/S Range
Min: 0.34  Med: 3.24 Max: 9.91
Current: 3.95
0.34
9.91
Current Ratio 3.09
STAA's Current Ratio is ranked higher than
68% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. STAA: 3.09 )
Ranked among companies with meaningful Current Ratio only.
STAA' s 10-Year Current Ratio Range
Min: 1.06  Med: 2.55 Max: 3.77
Current: 3.09
1.06
3.77
Quick Ratio 2.15
STAA's Quick Ratio is ranked higher than
65% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. STAA: 2.15 )
Ranked among companies with meaningful Quick Ratio only.
STAA' s 10-Year Quick Ratio Range
Min: 0.55  Med: 1.47 Max: 2.37
Current: 2.15
0.55
2.37
Days Inventory 214.96
STAA's Days Inventory is ranked lower than
81% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. STAA: 214.96 )
Ranked among companies with meaningful Days Inventory only.
STAA' s 10-Year Days Inventory Range
Min: 154.29  Med: 204.41 Max: 727.32
Current: 214.96
154.29
727.32
Days Sales Outstanding 63.01
STAA's Days Sales Outstanding is ranked higher than
50% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. STAA: 63.01 )
Ranked among companies with meaningful Days Sales Outstanding only.
STAA' s 10-Year Days Sales Outstanding Range
Min: 36.28  Med: 54.03 Max: 97.05
Current: 63.01
36.28
97.05

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 11.12
STAA's Price/Net Current Asset Value is ranked lower than
69% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.89 vs. STAA: 11.12 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
STAA' s 10-Year Price/Net Current Asset Value Range
Min: 2.23  Med: 12.16 Max: 45.33
Current: 11.12
2.23
45.33
Price/Tangible Book 7.76
STAA's Price/Tangible Book is ranked lower than
74% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. STAA: 7.76 )
Ranked among companies with meaningful Price/Tangible Book only.
STAA' s 10-Year Price/Tangible Book Range
Min: 0.94  Med: 7.05 Max: 23.8
Current: 7.76
0.94
23.8
Price/Projected FCF 24.03
STAA's Price/Projected FCF is ranked lower than
97% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. STAA: 24.03 )
Ranked among companies with meaningful Price/Projected FCF only.
STAA' s 10-Year Price/Projected FCF Range
Min: 0.87  Med: 6.86 Max: 128.14
Current: 24.03
0.87
128.14
Price/Median PS Value 1.23
STAA's Price/Median PS Value is ranked lower than
63% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. STAA: 1.23 )
Ranked among companies with meaningful Price/Median PS Value only.
STAA' s 10-Year Price/Median PS Value Range
Min: 0.13  Med: 0.99 Max: 3.01
Current: 1.23
0.13
3.01
Earnings Yield (Greenblatt) (%) -3.35
STAA's Earnings Yield (Greenblatt) (%) is ranked lower than
75% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. STAA: -3.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STAA' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -3.35  Med: 0.40 Max: 0.9
Current: -3.35
-3.35
0.9

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 74 82
EPS($) -0.17 -0.14
EPS without NRI($) -0.17 -0.14

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:SR3.Germany,
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses. The Company was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The lenses are used in corrective or refractive surgery. The Company also makes lenses for use in surgery that treats cataracts. The Company operates as one operating segment, the ophthalmic surgical market. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company competes with other elective surgical procedures such as laser vision correction or LASIK, for those consumers who are looking for an alternative to eyeglasses or contact lenses to correct their vision.
» More Articles for STAA

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlight: MHR, DISCA, BCR, STAA, PEGA, IDXX Aug 22 2011 
STAAR Surgical Generates Cash From Operations During Second Quarter Aug 03 2009 

More From Other Websites
Why STAAR Surgical (STAA) Could Be a Potential Winner Sep 01 2015
Redmile Group Fortifies Position In Array Biopharma Inc (ARRY); Broadwood Capital Boosts Stake In... Aug 26 2015
STAAR SURGICAL CO Financials Aug 19 2015
STAAR Surgical (STAA) Is in Oversold Territory: What's Next? Aug 14 2015
10-Q for STAAR Surgical Co. Aug 10 2015
STAAR SURGICAL CO Files SEC form 10-Q, Quarterly Report Aug 07 2015
Why STAAR Surgical (STAA) Might Be a Diamond in the Rough - Tale of the Tape Aug 07 2015
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure Aug 06 2015
Dr. Keith Holliday Named Vice President Research and Development for STAAR Surgical Aug 06 2015
Edited Transcript of STAA earnings conference call or presentation 29-Jul-15 8:30pm GMT Jul 29 2015
Staar Surgical reports 2Q loss Jul 29 2015
Staar Surgical reports 2Q loss Jul 29 2015
STAAR Surgical Company Earnings Call scheduled for 4:30 pm ET today Jul 29 2015
STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition Jul 29 2015
STAAR Surgical Reports Second Quarter 2015 Results Jul 29 2015
Q2 2015 STAAR Surgical Company Earnings Release - After Market Close Jul 29 2015
STAAR SURGICAL CO Files SEC form 8-K, Unregistered Sale of Equity Securities Jul 28 2015
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure Jul 23 2015
Dr. Jon K. Hayashida Named Vice President Global Clinical and Medical Affairs for STAAR Surgical Jul 23 2015
STAAR Surgical to Report Second Quarter Results on July 29, 2015 Jul 15 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK